Advertisement
U.S. markets open in 4 hours 3 minutes

IBC Advanced Alloys Corp. (IAALF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0470+0.0070 (+17.50%)
At close: 02:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0400
Open0.0433
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0433 - 0.0470
52 Week Range0.0300 - 0.1000
Volume100,058
Avg. Volume14,878
Market Cap5.017M
Beta (5Y Monthly)0.82
PE Ratio (TTM)N/A
EPS (TTM)-0.0300
Earnings DateFeb 16, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for IAALF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • IBC ADVANCED ALLOYS CORP
    Analyst Report: Moderna, Inc.Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
    Rating
    Fair Value
    Economic Moat
    15 hours agoMorningstar
View more